CoChat

Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects

The DOI matches its Crossref record; 95 of the 97 references it cites were found in a registry or an index.

Abstract

Background.: Magnetic seizure therapy (MST), despite being in an early phase of clinical research, has been demonstrated to be associated with antidepressant efficacy. However, safety, tolerability and efficacy data in connection with functional brain activity from larger samples are lacking. The aim of this study was to determine clinical and cognitive effects of MST and the influence of MST on regional brain glucose metabolism. Method.: Twenty-six patients suffering from treatment-resistant depression (TRD) underwent MST. Ten patients underwent a randomized trial and 16 patients an open-label study design. The primary outcome criterion was the severity of depressive symptoms assessed with the Hamilton Depression Rating Scale (HAMD). Depressive symptoms, tolerability and cognitive safety, along with social functioning and quality of life parameters, were assessed using various rating scales. A clinical follow-up visit 6 months following the completion of a course of MST and [18 F]-fluorodeoxyglucose positron emission tomography (FDG-PET) scans of 12 patients were analysed. Results.: A significant response to MST was demonstrated by 69% of the patient sample, with 46% meeting remission criteria. Anxiety ratings were significantly reduced in responders and their quality of life was improved. Half of the responders relapsed within 6 months. No cognitive side-effects were observed. FDG-PET scans showed a metabolic increase in the frontal cortex bilaterally and a decrease in the left striatum. Conclusions.: Robust antidepressant and anti-anxiety efficacy of MST was demonstrated, and found to be associated with localized metabolic changes in brain areas that are strongly implicated in depression. Thus, MST presents an effective, well-tolerated and safe treatment option for patients unable to respond to other forms of therapy for depression.

Overview

Integrity signals

Registry

Crossref · 10.1017/s0033291714002244

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Research works printed but not linked: 12

  1. Tewes, 1991, HAWIE-R. Hamburg-Wechsler Intelligenztest fuer Erwachsene
  2. Weiner, 1993, EEG Monitoring of ECT Seizures
  3. Bernstein, 1996, Developmental Scoring System for the Rey-Osterrieth Complex Figure: Professional Manual
  4. Brickenkamp, 1962, d2. Aufmerksamkeits-Belastungs-Test
  5. 2001, The Practice of ECT: Recommendations for Treatment, Training and Privileging
  6. Regard, 1982, Der Fuenf-Punkt Test
  7. Aschenbrenner, 2000, RWT Regensburger Wortflüssigkeits-Test. Handanweisung
  8. Haerting, 2000, WMS-R. Wechsler Memory Scale – Revised
  9. Hamilton, 1976, HAMA. Hamilton Anxiety Scale
  10. Lehrl, 2005, MWT-B. Mehrfachwahl-Wortschatz-Intelligenztest
  11. Franke, 1995, SCL-90-R. The Symptom Checklist of Derogatis Revised. German Version
  12. Helmstaedter, 2001, VLMT. Verbaler Lern- und Merkfähigkeitstest

Cited by

See all 94

Metadata

Authors
Kayser, S., Bewernick, B. H., Matusch, A., Hurlemann, R., Soehle, M., & Schlaepfer, T. E.
Affiliations
  • University of Bonn (DE)
  • Forschungszentrum Jülich (DE)
Corresponding author
Schlaepfer, T. E.
Venue
Psychological Medicine
Published
2014-11-25
Volume
45
Issue
5
Pages
1073-1092
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W1989056327
Cited by
94
References
97
Citations by year
2026: 8 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 8 · 2020: 13 · 2019: 10 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 3
FWCI
5.85
Type
journal article
Language
en
Open access
closed
Locations
  • Psychological Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
magnetic seizure therapy, treatment-resistant depression, antidepressant efficacy, anxiolytic effects, quality of life, relapse, cognitive safety, brain glucose metabolism, frontal cortex, striatum, FDG-PET, neuropsychological outcomes
MeSH terms
Adult, Anxiety, Brain, Convulsive Therapy, Female, Frontal Lobe, Humans, Male, Middle Aged, Quality of Life, Recurrence, Treatment Outcome, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Magnetic Field Therapy, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. https://app.cochat.ai/papers/10.1017/s0033291714002244
The paper
Kayser, S., Bewernick, B. H., Matusch, A., Hurlemann, R., Soehle, M., & Schlaepfer, T. E. (2015). Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychological Medicine. https://doi.org/10.1017/s0033291714002244

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.